Table 1.
Characteristic | CHC | Normal controls |
---|---|---|
Sex | ||
Male | 188/267 (70%) | 56/100 (56%) |
Female | 79/267 (30%) | 44/100 (44%) |
Ethnicity | ||
Caucasian | 213/267 (80%) | 65 (65%) |
Black | 6/267 (2%) | 32 (32%) |
Latino | 32/267 (12%) | |
Other or unknown | 16/267 (6%) | 3 (3%) |
Age (median, IQR) | 44 (40–48) | 41.5 (31–48) |
BMI (median, IQR) | 26.8 (25–30) | 27 (24–30) |
ALT IU/L (median, IQR) | 87.0 (50–130) | 9 (7–13) |
Genotype | ||
1 | 156/267 (58%) | na |
2 | 40/267 (15%) | |
3 | 53 (20%) | |
4 | 3 (1%) | |
6 | 2 (<1%) | |
Unknown | 13/267 (5%) | |
Fat grade | ||
0 | 130 (49%) | na |
1 | 92 (35%) | |
2 | 31 (12%) | |
3 | 14 (5%) | |
Fibrosis stage | ||
0 | 35 (13%) | na |
1 | 125 (47%) | |
2 | 42 (16%) | |
3 | 35 (13%) | |
4 | 30 (11%) | |
Inflammation | ||
0–5 | 79 (31%) | na |
6–10 | 110 (44%) | |
11–16 | 62 (25%) |
CHC, chronic hepatitis C, BMI, body mass index, ALT, alanine aminotransferase; na, not applicable.